Literature DB >> 27230768

How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings?

Loredana Pagano1, Chiara Mele2, Debora Arpaia3, Maria Teresa Samà2, Marina Caputo2, Serena Ippolito3, Carmela Peirce3, Flavia Prodam4, Guido Valente2, Giuseppe Ciancia5, Gianluca Aimaretti2, Bernadette Biondi3.   

Abstract

The aim was to retrospectively analyse the clinical-histopathological characteristics of patients with newly diagnosis of differentiated thyroid cancer (DTC) referred to two Italian centres, one in Northern and the other in Southern Italy, between 2000 and 2013. 1081 patients were included and subdivided into two groups: group A (474 patients from Novara) and group B (607 patients from Naples). The group A came from the industrial area of Novara, while the Group B came from the areas around Vesuvius and Campi Flegrei. The two groups were comparable for iodine levels, body mass index, diagnostic timing and clinical procedures. For all patients, demographic and clinical data were collected. No difference was found in gender, whereas the age at diagnosis was later in the group A (group A 53.1 ± 15.16 years, group B 41.9 ± 14.25 years, p < 0.001). In both groups, the most frequent histotype was papillary thyroid cancer (PTC) with prevalence of follicular variant in group A (p < 0.0001) and classical variant in group B (p < 0.0001). Aggressive histological features were mainly seen in group A (bilaterality p < 0.0001, multifocality p < 0.0001 and thyroid capsular invasion p < 0.0001). Microcarcinomas were more frequent in group A (p < 0.0001) but mostly characterized by bilaterality (p < 0.001) and multifocality (p < 0.04). In both groups, tumour-associated thyroiditis showed a significant increase over the years (group A p < 0.05, group B p < 0.04). Environmental factors could justify the differences found in our study. These preliminary data should stimulate the need for an Italian Cancer Registry of DTC in order to allow an epidemiological characterization, allowing the identification of specific etiological factors and an improvement in the management of the disease.

Entities:  

Keywords:  Clinical–histopathological features; Environmental factors; Thyroid cancer; Tumourigenesis induction

Mesh:

Year:  2016        PMID: 27230768     DOI: 10.1007/s12020-016-0992-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  44 in total

1.  Occupational risks of thyroid cancer: data from the Swedish Cancer-Environment Register, 1961-1979.

Authors:  J M Carstensen; G Wingren; T Hatschek; M Fredriksson; H Noorlind-Brage; O Axelson
Journal:  Am J Ind Med       Date:  1990       Impact factor: 2.214

2.  Clinical and molecular analyses of thyroid cancer in patients treated for benign diseases.

Authors:  Simone De Leo; Michela Perrino; Sara Badiali; Stefania Rossi; Valentina Cirello; Carla Colombo; Delfina Tosi; Gianmaria Cantoni; Luca Poggi; Gaetano Bulfamante; Paolo Beck-Peccoz; Leonardo Vicentini; Laura Fugazzola
Journal:  Endocr Relat Cancer       Date:  2013-07-05       Impact factor: 5.678

Review 3.  Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008.

Authors:  Nan Li; Xianglin L Du; Lorraine R Reitzel; Li Xu; Erich M Sturgis
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

4.  Thyroid cancer incidence in relation to volcanic activity.

Authors:  E Arnbjörnsson; A Arnbjörnsson; A Olafsson
Journal:  Arch Environ Health       Date:  1986 Jan-Feb

5.  Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

Authors:  Jeffrey Liu; Bhuvanesh Singh; Giovanni Tallini; Diane L Carlson; Nora Katabi; Ashok Shaha; R Michael Tuttle; Ronald A Ghossein
Journal:  Cancer       Date:  2006-09-15       Impact factor: 6.860

6.  Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries.

Authors:  Pasqualino Malandrino; Gabriella Pellegriti; Marco Attard; Maria Antonia Violi; Carla Giordano; Laura Sciacca; Concetto Regalbuto; Sebastiano Squatrito; Riccardo Vigneri
Journal:  J Clin Endocrinol Metab       Date:  2013-03-12       Impact factor: 5.958

7.  Increasing incidence of thyroid cancer is due to increased pathologic detection.

Authors:  Simon Grodski; Tani Brown; Stan Sidhu; Anthony Gill; Bruce Robinson; Diana Learoyd; Mark Sywak; Tom Reeve; Leigh Delbridge
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

8.  Papillary thyroid cancer incidence in the volcanic area of Sicily.

Authors:  Gabriella Pellegriti; Florent De Vathaire; Claudia Scollo; Marco Attard; Carla Giordano; Salvatore Arena; Gabriella Dardanoni; Francesco Frasca; Pasqualino Malandrino; Francesco Vermiglio; Domenico Massimo Previtera; Girolamo D'Azzò; Francesco Trimarchi; Riccardo Vigneri
Journal:  J Natl Cancer Inst       Date:  2009-11-05       Impact factor: 13.506

9.  Iodine status assessment in Campania (Italy) as determined by urinary iodine excretion.

Authors:  Claudia Mazzarella; Daniela Terracciano; Angelina Di Carlo; Paolo Emidio Macchia; Eduardo Consiglio; Vincenzo Macchia; Angela Mariano
Journal:  Nutrition       Date:  2009-09       Impact factor: 4.008

10.  Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.

Authors:  Gabriella Pellegriti; Francesco Frasca; Concetto Regalbuto; Sebastiano Squatrito; Riccardo Vigneri
Journal:  J Cancer Epidemiol       Date:  2013-05-07
View more
  5 in total

1.  Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.

Authors:  Maria Teresa Samà; Enrico Grosso; Chiara Mele; Sara Laurora; Oriana Monzeglio; Paolo Marzullo; Renzo Boldorini; Paolo Aluffi Valletti; Gianluca Aimaretti; Maria Scatolini; Loredana Pagano
Journal:  Endocrine       Date:  2020-07-03       Impact factor: 3.633

2.  Thyroid Cancer Epidemiology in South Spain: a population-based time trend study.

Authors:  Elena Salamanca-Fernández; Miguel Rodriguez-Barranco; Yoe-Ling Chang-Chan; Daniel Redondo-Sánchez; Santiago Domínguez-López; Eloísa Bayo; Dariusz Narankiewicz; José Expósito; María José Sánchez
Journal:  Endocrine       Date:  2018-07-24       Impact factor: 3.633

Review 3.  Adiponectin and Thyroid Cancer: Insight into the Association between Adiponectin and Obesity.

Authors:  Yuanyuan Zhou; Ying Yang; Taicheng Zhou; Bai Li; Zhanjian Wang
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

4.  Circulating adipokines and metabolic setting in differentiated thyroid cancer.

Authors:  Chiara Mele; Maria Teresa Samà; Alessandro Angelo Bisoffi; Marina Caputo; Valentina Bullara; Stefania Mai; Gillian Elisabeth Walker; Flavia Prodam; Paolo Marzullo; Gianluca Aimaretti; Loredana Pagano
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

5.  The role of metabolic setting in predicting the risk of early tumour relapse of differentiated thyroid cancer (DTC).

Authors:  Chiara Mele; Marina Caputo; Maria Teresa Samà; Valentina Bullara; Maria Grazia Mauri; Flavia Prodam; Gianluca Aimaretti; Loredana Pagano; Paolo Marzullo
Journal:  Eur J Clin Nutr       Date:  2020-06-09       Impact factor: 4.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.